Sanomedics International Holdings Appoints Dr. Anand Akerkar to the Medical Advisory Board

Dr. Akerkar has over 40 years of experience in the healthcare industry

Co-founder of mdi Consultants Inc. provides FDA 510(k) and ISO 9000:2000, ISO
14000, ISO 13485:1997 (EN46001), EN540 and Quality Systems

mdi Consultants has helped over 500 companies achieve FDA or ISO compliance and
Submitted over 400 510(k)s
MIAMI--(Business Wire)--
Sanomedics International Holdings Inc. (Pink Sheets:SIMH): Keith Houlihan,
President and Director of International Sales, today announced the introduction
of Dr. Anand Akerkar as the distinguished member of the Sanomedics International
Holdings Medical Advisory Board.

"Dr. Akerkar is an internationally respected regulatory medical device expert
who brings to Sanomedics insight and expertise to the growing field of home
diagnostic medical devices," said Keith Houlihan, President. "The health
consumer is entering uncharted territory when it comes to making decisions about
which home medical diagnostic devices to purchase. With Dr. Akerkar leading our
medical advisory board, consumers can be confident that Sanomedics has the
expertise and direction to provide the right device at the right time."

Dr. Akerkar has 40 years of experience in the healthcare industry. Anand held
several senior management positions at Ciba Giegy, Becton Dickinson, and
Technicon Corporation. Dr. Akerkar has successfully managed the development,
launch and management of in-vitro diagnostic products. While at Becton
Dickinson, he was a member of the industry review board for the FDA that helped
to define the 510(k) submission requirements and other clinical chemistry
standards. Dr. Akerkar holds 11 patents and has been published over 150 times in
recognized scientific journals. Dr. Akerkar was instrumental in getting over 400
FDA 510(k) for over 500 medical devices companies. Dr. Akerkar has been a
consultant to the healthcare industry since 1986. Dr. Akerkar was the Scientific
Advisor to ex-U.S. Congressman Benjamin Gilman and advised the scientific
committee previously led by former House Majority Leader - Congressman Tom
Delay. He has been President and CEO of mdi since 1994.

"We are excited to be working with Sanomedics and their newly formed Medical
Advisory Board to identify and bring to market home medical diagnostics devices
that are easy to use and cost effective," said Dr. Akerkar. "The work of
Sanomedics and experience of mdi Consultants provide a fresh vision that
recognizes the growing importance of the individual and family in taking
personal responsibility and control of their health."

About Sanomedics

Sanomedics International Inc (SIMH) manufactures and distributes medical and
home health products. A pioneer in the trend for preventive medicine, the
Sanomedics goal is to act as a bridge between the medical world and home.
Sanomedics home healthcare products are easy to use and can be found in any home
medicine cabinet or doctors office. Sanomedics Development Corporation
identifies new solutions for the healthcare industry to improve quality, reduce
cost and create greater operating efficiencies.

About mdi Consultants

mdi Consultants, Inc. is a leader in providing consulting services to the
healthcare industry worldwide with extensive expertise in helping medical
device, pharmaceutical, biotechnology and food companies achieve compliance with
U.S., European and Canadian regulations. The company's principals, Alan P.
Schwartz and Dr. Anand Akerkar have carefully selected a group of consultants
who have accumulated extensive industry experience dealing with U.S., European
and Canadian compliance concerns. mdi Consultants have has deep knowledge in all
FDA compliance issues (e.g. device and pharmaceutical submissions, quality
system compliance, clinical trial management) as well as European compliance
issues (e.g. ISO 9000, ISO 13485, ISO 14000, CE Mark, MDD, IVDD, AIMDD). The
staff includes a number of former FDA officials, ISO lead assessors and industry
quality managers.

Forward Looking Statements

This press release may contain statements which constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including statements regarding the intent belief or current expectations
of the Company, its directors, or its officers with respect to the future
operating performance of the Company Investors are cautioned that any such
forward-looking statements are not guarantees of future performance and involve
risks and uncertainties, and that actual results may differ materially from
those in the forward-looking statements as a result of various factors. The
Company's periodic filings with the Securities and Exchange Commission should be
viewed for a complete understanding of risk and uncertainty.

www.sanomedics.com

©2009 Sanomedics International Holdings Inc. All rights reserved.

Sanomedics International Holdings Inc.
Keith Houlihan, 305-433-7814

Copyright Business Wire 2009